Document:

EX-10.1

AMENDED AND RESTATED EMPLOYMENT AGREEMENT

This Amended and Restated Employment Agreement (“Agreement”), dated as of June 1, 2010 is made and
entered into by BRETT R. CHAPMAN (“Executive”) and HERBALIFE INTERNATIONAL OF AMERICA, INC., a
California corporation (“Company”). The parties to this Agreement agree as follows:

1. Employment At-Will. The Company and Executive acknowledge and agree that each can
terminate the employment relationship at any time upon written notice to the other, with or without
prior notice, for any reason or for no reason. Executive has received no promise of continued
employment or employment for any specific period of time, and no employee of the Company, including
without limitation the Company’s officers, has the authority to alter the at-will nature of the
employment relationship except in a written employment contract signed by an authorized Company
executive and by Executive.

2. Duties. Executive shall serve in the Los Angeles, California area as General Counsel of
the Company, with all of the authority, duties, and responsibilities commensurate with such
position. Executive shall report only to the Chief Executive Officer or Chairman of the Company.
Executive’s service on any outside board of directors, including any non-profit board, shall be
subject to joint approval by the Chief Executive Officer and the Company’s Board of Directors (the
“Board”); provided, however, the board set forth in Schedule A attached hereto is deemed approved.

3. Compensation and Related Matters.

(a) Salary. Executive shall receive a salary (the “Salary”) at the per annum rate
of Six Hundred Fifteen Thousand Five Hundred Dollars ($615,500), payable in accordance with
the Company’s payroll practices for Senior Executives (as defined in Section 3(b) below).
Executive’s Salary shall be subject to an annual review and adjustment in the discretion of
the Chief Executive Officer, subject to approval by the Board’s Compensation Committee.
Executive’s Salary shall be subject to a reduction of not more than ten percent in the event
that the Company adopts an across-the-board reduction for Senior Executives and the Chief
Executive Officer, in which event such percentage reduction shall not exceed the smallest
percentage reduction imposed on any Senior Executive or the Chief Executive Officer.

(b) Employee Benefits. Executive and Executive’s qualified dependents shall be
entitled to participate in or receive benefits under each benefit plan or arrangement made
available by the Company to its most senior executives (including its President and Chief
Operating Officer but specifically excluding its Chief Executive Officer (“Senior
Executives”)) including, without limitation, those relating to group medical, dental,
vision, long-term disability, D&O, accidental death and dismemberment, and life insurance,
subject to and on a basis consistent with the terms, conditions and overall administration
of such plans and subject to the Company’s right to modify, amend or terminate any such plan
or arrangement with or without prior notice. Executive shall be eligible to participate in
the Company’s 401K program and the Company’s Deferred Compensation program. Executive shall
be entitled to reimbursement of reasonable business expenses in accordance with the
Company’s practices and procedures. Executive shall be entitled to paid vacation in
accordance with Company policy.

(c) Bonus. If the Company shall achieve the applicable bonus target set annually by
the Board’s Compensation Committee (the “Performance Target”), then the Company shall pay
Executive a cash bonus in an amount equal to one hundred percent (100%) of Executive’s
Target Bonus (as defined below) calculated in accordance with the Company’s then current
bonus plan in effect for its Senior Executives. The Performance Target utilized for
calculating Executive’s bonus shall be the same as that utilized in calculating the base
bonus (and not the APT bonus) for its Chief Executive Officer for so long as Mr. Michael O.
Johnson serves as the Company’s Chief Executive Officer. If Mr. Michael O. Johnson ceases
to serve as the Company’s Chief Executive Officer, the Performance Target utilized for
calculating Executive’s bonus shall be determined by the Board’s Compensation Committee.
Executive’s “Target Bonus” shall be in an amount no less than fifty-five percent of
Executive’s annual salary for the year with respect to which the bonus is to be paid. Any
bonus will be paid in the calendar year following the calendar year to which such bonus
relates at such time bonuses are paid to the Company’s other Senior Executives.

(d) Long-Term Incentives. Executive shall be eligible to participate in the
Company’s long-term incentive plan for Senior Executives, if any. The size, form, and
timing of grants, if any, shall be consistent with competitive practice, internal position
responsibilities, and subject to the joint approval of the Chief Executive Officer and the
Board’s Compensation Committee.

4. Severance.

(a) Although nothing in this Section 4 shall be construed to alter the at-will nature of
employment as set forth in Section 1 above, if Executive is terminated by the Company
without Cause or resigns for Good Reason, Executive will be paid a lump sum amount equal to
two times Executive’s then-current annual salary (the “Salary Severance”), in addition to
all other accrued entitlements such as unpaid salary and accrued vacation, if any. If
Executive is terminated by the Company without Cause or resigns for Good Reason, the Company
will also provide Executive with outplacement services for up to six months by a provider
selected and paid for by the Company in an amount not to exceed $20,000; Executive shall not
be entitled to cash in lieu of outplacement services. If Executive is terminated by the
Company without Cause, resigns for Good Reason, retires, dies, or resigns as a result of a
disability, Executive will be entitled to receive a pro rata bonus payment (based on the
actual performance of the Company over the entire year), at such time bonuses are paid to
the Company’s other Senior Executives, based on the number of months worked in the
applicable fiscal year of the Company (the “Bonus Severance”). Executive will have no duty
to mitigate. As a precondition to the Company’s obligation to pay Executive severance of
two years of salary and a pro rata bonus, Executive agrees to execute and deliver to the
Company a fully effective general release in the form attached to this Agreement as
Attachment A within 30 days following the date Executive’s employment with the Company
terminates. Company shall pay Executive the Salary Severance on the date which is the later
of ten days after the date on which it receives the signed release (so long as such release
has become effective and irrevocable in accordance with its terms), subject to Section 21,
and the Company shall pay the Bonus Severance on the date which is the later of ten days
after the date on which it receives the signed release (so long as such release has become
effective and irrevocable in accordance with its terms) or the date on which Company pays
bonuses to Company’s Senior Executives for the applicable year (such date to be in the
calendar year following the year in which the separation from service occurs), subject to
Section 21. Executive understands and agrees that Executive shall not be entitled to any
other severance benefit not set forth in this Section 4, and accordingly Executive expressly
acknowledges that the Company will not be obligated to make 401(k) contributions following
the termination of Executive’s employment.

(b) In the event that Executive is qualified for and elects COBRA coverage under the
Company’s health plans after a termination without Cause or a resignation for Good Reason,
the Company will continue to pay its share of the cost of premiums under such plans until
Executive is reemployed, or for a period of two years, whichever occurs first, payable in
accordance with the Company’s normal benefit practices. Upon a termination for Cause and
upon a resignation without Good Reason (other than due to death, disability or retirement),
except as set forth in Section 4(a) above and/or one or more separate written agreements
between Company and Executive, all unearned compensation, benefits and unvested options
shall be forfeited.

(c) Notwithstanding the terms of any stock incentive plan of the Company or stock option or
stock appreciation right agreement to which Executive is a party, if Executive is terminated
by the Company without Cause or resigns for Good Reason, and on the effective date of such
termination Executive is subject to a “trading blackout” or “quiet period” with respect to
the Company’s common shares or if the Company determines, upon the advice of legal counsel,
that on the effective date of such termination Executive may not to trade in the Company’s
common shares due to Executive’s possession of material non-public information, in each
case, which restriction or prohibition continues for a period of at least twenty consecutive
calendar days, the Company hereby agrees that Executive shall be permitted to pay the
exercise price and/or any tax withholding obligation payable in connection with the exercise
of any of Executive’s then outstanding and exercisable Company stock options and/or stock
appreciation rights by either tendering common shares of the Company then owned by Executive
and/or instructing the Company to withhold from the common shares otherwise issuable upon
exercise such stock options and/or stock appreciation rights a number of common shares
having a fair market value on the date of exercise equal to the exercise price and/or tax
withholding obligation.

(d) For purposes of this Agreement, the Company shall have “Cause” to terminate Executive’s
services in the event of any of the following acts or circumstances: (i) Executive’s
conviction of a felony or entering a plea of guilty or nolo contendere to any crime
constituting a felony (other than a traffic violation or by reason of vicarious liability);
(ii) Executive’s substantial and repeated failure to attempt to perform Executive’s lawful
duties as contemplated in Section 2 of this Agreement, except during periods of physical or
mental incapacity; (iii) Executive’s gross negligence or willful misconduct with respect to
any material aspect of the business of the Company or any of its affiliates, which gross
negligence or willful misconduct has a material and demonstrable adverse effect on the
Company; (iv) Executive’s material violation of a Company policy resulting in a material and
demonstrable adverse effect to the Company or an affiliate, including but not limited to a
violation of the Company’s Code of Business Conduct and Ethics; or (v) any material breach
of this Agreement or any material breach of any other written agreement between Executive
and the Company’s affiliates governing Executive’s equity compensation arrangements (i.e.,
any agreement with respect to Executive’s stock, stock appreciation right and/or stock
options of any of the Company’s affiliates); provided, however, that Executive shall not be
deemed to have been terminated for Cause in the case of clause (ii), (iii), (iv) or (v)
above, unless any such breach is not fully corrected prior to the expiration of the thirty
(30) calendar day period following delivery to Executive of the Company’s written notice of
its intention to terminate his employment for Cause describing the basis therefore in
reasonable detail.

(e) Executive will be deemed to have a “Good Reason” if Executive terminates his employment
because of (i) a material diminution of Executive’s duties as General Counsel, (ii) the
failure by any successor of the Company to assume in writing the Company’s obligations under
this Agreement, (iii) the breach by the Company in any respect of any of its obligations
under this Agreement, and, in any such case (but only if correction or cure is possible),
the failure by the Company to correct or cure the circumstance or breach on which such
resignation is based within 30 days after receiving notice from Executive describing such
circumstance or breach in reasonable detail, (iv) the relocation of Executive’s primary
office location of more than 50 miles that places the primary office farther from
Executive’s residence than it was before, or (v) the imposition by the Company of a
requirement that Executive report to a person other than the Chief Executive Officer of the
Company or the Chairman of the Board. Executive shall not have a Good Reason to resign if
the Company suspends Executive due to an indictment of Executive on felony charges, provided
that the Company continues to pay Executive’s salary and benefits.

5. Adjustment to Payments Triggering Excise Tax. In the event that any amount or benefit
that may be paid or otherwise provided to or in respect of Executive by the Company or any
affiliated company, whether pursuant to this Agreement or otherwise (collectively, “Covered
Payments”), is or may become subject to the tax imposed under Section 4999 of the Internal Revenue
Code of 1986, as amended (the “Code”), or any successor provision (“Excise Tax”), the Company shall
promptly pay to Executive a “Reimbursement Amount,” defined as an amount, which when added to the
Covered Payments and after taking into account any federal, state or local tax resulting from the
Covered Payment and the Reimbursement Amount will provide Executive with after tax net income equal
to the amount Executive would have earned had no Excise Tax been imposed on the Covered Payments,
no later than the end of the calendar year following the year in which Executive remits the Excise
Tax.

1

6. Confidential and Proprietary Information.

(a) The parties agree and acknowledge that during the course of Executive’s employment,
Executive will be given and will have access to and be exposed to trade secrets and
confidential information in written, oral, electronic and other forms regarding the Company
and its affiliates (which includes but is not limited to all of its business units,
divisions and affiliates) and their business, equipment, products and employees, including,
without limitation: the identities of the Company’s and its affiliates’ distributors and
customers and potential distributors and customers (hereinafter referred to collectively as
“Distributors”), including, without limitation, the identity of Distributors that Executive
cultivates or maintains while providing services at the Company or any of its affiliates
using the Company’s or any of its affiliates’ products, name and infrastructure, and the
identities of contact persons with respect to those Distributors; the particular
preferences, likes, dislikes and needs of those Distributors and contact persons with
respect to product types, pricing, sales calls, timing, sales terms, rental terms, lease
terms, service plans, and other marketing terms and techniques; the Company’s and its
affiliates’ business methods, practices, strategies, forecasts, pricing, and marketing
techniques; the identities of the Company’s and its affiliates’ licensors, vendors and other
suppliers and the identities of the Company’s and its affiliates’ contact persons at such
licensors, vendors and other suppliers; the identities of the Company’s and its affiliates’
key sales representatives and personnel and other employees; advertising and sales
materials; research, computer software and related materials; and other facts and financial
and other business information concerning or relating to the Company or any of its
affiliates and their business, operations, financial condition, results of operations and
prospects. Executive expressly agrees to use such trade secrets and confidential
information only for purposes of carrying out his duties for the Company and its affiliates
as he deems appropriate in his good faith judgment, and not for any other purpose,
including, without limitation, not in any way or for any purpose that could reasonably be
foreseen to be detrimental to the Company or any of its affiliates; provided, Executive
shall be permitted to disclose such trade secrets and confidential information to third
parties in the course of performing his duties for the Company and its affiliates as he
deems appropriate in his good faith judgment provided that prior to such disclosure
Executive causes the intended recipient of such information to sign a confidentiality
agreement. Executive shall not at any time, either during the course of his employment
hereunder or after the termination of such employment, use for himself or others, directly
or indirectly, any such trade secrets or confidential information, and, except as required
by law or as permitted hereunder, Executive shall not disclose such trade secrets or
confidential information, directly or indirectly, to any other person or entity. Trade
secret and confidential information hereunder shall not include any information which (i) is
already in or subsequently enters the public domain, other than as a result of any
unauthorized direct or indirect disclosure by Executive, (ii) becomes available to Executive
on a non-confidential basis from a source other than the Company or any of its affiliates,
provided that Executive has no knowledge that such source is subject to a confidentiality
agreement or other obligation of secrecy or confidentiality (whether pursuant to a contract,
legal or fiduciary obligation or duty or otherwise) to the Company or any of its affiliates
or any other person or entity or (iii) is approved for release by the Chief Executive
Officer or the board of directors of the Company or any of its affiliates or which the Chief
Executive Officer or the board of directors of the Company or any of its affiliates makes
available or authorizes Executive to make available to third parties without an obligation
of confidentiality.

(b) All physical property and all notes, memoranda, files, records, writings, documents and
other materials of any and every nature, written or electronic, which Executive shall
prepare or receive in the course of his employment with the Company and which relate to or
are useful in any manner to the business now or hereafter conducted by the Company or any of
its affiliates are and shall remain the sole and exclusive property of the Company and its
affiliates, as applicable. Executive shall not remove from the Company’s premises any such
physical property, the original or any reproduction of any such materials nor the
information contained therein except for the purposes of carrying out his duties to the
Company or any of its affiliates and all such property (except for any items of personal
property not owned by the Company or any of its affiliates), materials and information in
his possession or under his custody or control upon the termination of his employment (other
than such materials received by Executive solely in his capacity as a shareholder) or at any
other time upon request by the Company shall be immediately turned over to the Company and
its affiliates, as applicable.

(c) All inventions, improvements, trade secrets, reports, manuals, computer programs, tapes
and other ideas and materials developed or invented by Executive during the period of his
employment, either solely or in collaboration with others, which relate to the actual or
anticipated business or research of the Company or any of its affiliates which result from
or are suggested by any work Executive may do for the Company or any of its affiliates or
which result from use of the Company’s or any of its affiliates’ premises or property
(collectively, the “Developments”) shall be the sole and exclusive property of the Company
and its affiliates, as applicable. Executive assigns and transfers to the Company his entire
right and interest in any such Development, and Executive shall execute and deliver any and
all documents and shall do and perform any and all other acts and things necessary or
desirable in connection therewith that the Company or any of its affiliates may reasonably
request, it being agreed that the preparation of any such documents shall be at the
Company’s expense. Nothing in this paragraph applies to an invention which qualifies fully
under the provisions of California Labor Code Section 2870.

(d) Following the termination of Executive’s employment, Executive will reasonably cooperate
with the Company (at the Company’s expense, if Executive reasonably incurs any out-of-pocket
costs with respect thereto, including, but not limited to, lost salary or the value of
vacation benefits used in connection therewith) in any defense of any legal, administrative
or other action in which the Company or any of its affiliates or any of their distributors
or other business relations are a party or are otherwise involved, so long as any such
matter was related to Executive’s duties and activities conducted on behalf of the Company
or its Subsidiaries.

(e) The provisions of this Section 6 and Section 7 shall survive any termination of this
Agreement and termination of Executive’s employment with the Company.

7. Non-Solicitation. Executive acknowledges that in the course of his employment for the
Company he will become familiar with the Company’s and its affiliates’ trade secrets and other
confidential information concerning the Company and its affiliates. Accordingly, Executive agrees
that, during Executive’s employment and for a period of twenty-four (24) months immediately
thereafter (the “Nonsolicitation Period”), he will not directly or indirectly through another
entity unlawfully (i) induce or attempt to induce any employee or Distributor of the Company or any
of its affiliates to leave the employment of, or cease to maintain its distributor relationship
with, the Company or such affiliate, or in any way interfere with the relationship between the
Company or any such affiliate and any employee or Distributor thereof, (ii) hire any person who was
an employee of the Company or any of its affiliates at any time during the Nonsolicitation Period
unless such person’s employment was terminated by the Company or such affiliate or enter into a
distributor relationship with any person or entity who was a Distributor of the Company or any of
its affiliates at any time during the Nonsolicitation Period, (iii) induce or attempt to induce any
Distributor, supplier, licensor, licensee or other business relation of the Company or any of its
affiliates to cease doing business with the Company or such affiliate, or in any way interfere with
the relationship between such Distributor, supplier, licensor, licensee or business relation and
the Company or any of its affiliates or (iv) use any trade secrets or other confidential
information of the Company or any of its affiliates to directly or indirectly participate in any
means or manner in any business which is a direct competitor of the Company.

8. Non-Disparagement. During Executive’s employment and thereafter, Executive agrees not
to make any derogatory, negative or disparaging public statement about the Company, its officers,
its employees, or members of its Board, or to make any public statement (or any statement likely to
become public) that could reasonably be expected to adversely affect or disparage the reputation,
or, to the extent applicable, business or goodwill of the Company, it being agreed and understood
that nothing herein shall prohibit Executive (a) from disclosing that Executive is no longer
employed by the Company, (b) from responding truthfully to any governmental investigation or
inquiry related thereto, whether by the Securities and Exchange Commission or other governmental
entity or any other law, subpoena, court order or other compulsory legal process or any disclosure
requirement of the Securities and Exchange Commission, or (c) from making traditional competitive
statements in the course of promoting a competing business, so long as any statements made by
Executive described in this clause (c) are not based on confidential information obtained during
the course of Executive’s employment with the Company. The Company agrees that it will not make any
derogatory, negative or disparaging public statements about Executive that are untruthful in any
authorized Company statement (whether written or oral), including, but not limited to, any press
release or public announcement.

9. Injunctive Relief. Executive and the Company (a) intend that the provisions of Sections
6 and 7 be and become valid and enforceable, (b) acknowledge and agree that the provisions of
Sections 6 and 7 are reasonable and necessary to protect the legitimate interests of the business
of the Company and its affiliates and (c) agree that any violation of Section 6 or 7 might result
in irreparable injury to the Company and its affiliates, the exact amount of which would be
difficult to ascertain and the remedies at law for which may not be reasonable or adequate
compensation to the Company and its affiliates for such a violation. Accordingly, Executive agrees
that if Executive violates or threatens to violate the provisions of Section 6 or 7, in addition to
any other remedy which may be available at law or in equity, the Company shall be entitled to seek
specific performance and injunctive relief, and without the necessity of proving actual damages. In
addition, in the event of a violation or threatened violation by Executive of Section 6 or 7 of
this Agreement, the Nonsolicitation Period will be tolled until such violation or threatened
violation has been duly cured. If, at the time of enforcement of Sections 6 or 7 of this Agreement,
a court holds that the restrictions stated therein are unreasonable under circumstances then
existing, the parties hereto agree that the maximum period, scope or geographical area reasonable
under such circumstances shall be substituted for the stated period, scope or area.

10. Indemnification. The Company shall indemnify Executive to the fullest extent permitted
by applicable law as more fully described in the Indemnification Agreement between the Company and
Executive; in the event that California law is deemed to apply and to permit the Company to provide
more indemnification to Executive for the matters described in the Indemnification Agreement, the
Company agrees to provide such indemnification to the fullest extent permitted under California
law.

11. Assignment: Successors and Assigns. Executive agrees that he shall not assign, sell,
transfer, delegate or otherwise dispose of, whether voluntarily or involuntarily, any rights or
obligations under this Agreement, nor shall Executive’s rights hereunder be subject to encumbrance
of the claims of creditors. This Agreement may be assigned by the Company without the consent of
Executive to (a) any entity succeeding to all or substantially all of the assets or business of the
Company, whether by merger, consolidation, acquisition or otherwise (upon which entity the
Agreement shall be binding), or (b) any affiliate; provided, however, that in neither case shall
the Company be released from its obligations hereunder, nor shall any assignment to an affiliate
lessen Executive’s rights with respect to his position, duties, responsibilities or authority with
respect to the Company.

12. Governing Law: Jurisdiction and Venue. This Agreement shall be governed, construed,
interpreted and enforced in accordance with the substantive laws of the State of California without
regard to the conflicts of law principles thereof. Suit to enforce this Agreement or any provision
or portion thereof may be brought in the federal or state courts located in Los Angeles,
California.

13. Severability of Provisions. In the event that any provision of this Agreement should
ever be adjudicated by a court of competent jurisdiction to be unenforceable, then such provision
shall be deemed reformed to the maximum extent permitted by applicable law, and the invalidity or
unenforceability of any provision shall not affect the validity or enforceability of any other
provision of this Agreement.

14 Warranty. As an inducement to the other party to enter into this Agreement, subject to
the termination of Executive’s Employment Agreement as set forth in paragraph 17 below, each party
represents and warrants to the other that it/he has the power and authority to enter into this
Agreement and is not a party to any other agreement or obligation, and that there exists no
impediment or restraint, contractual or otherwise, on its/his power, right or ability to enter into
this Agreement and to perform its/his duties and obligations hereunder.

15. Notices. All notices, requests, demands and other communications which are required or
may be given under this Agreement shall be in writing and shall be deemed to have been duly given
when received if personally delivered; when transmitted if transmitted by telecopy, electronic or
digital transmission method upon receipt of telephonic or electronic confirmation; the day after it
is sent, if sent for next day delivery to a domestic address by recognized overnight delivery
service (e.g., Federal Express); and upon receipt, if sent by certified or registered mail, return
receipt requested. In each case notice will be sent to:

(a) If to the Company:

Herbalife International of America, Inc.

800 W. Olympic Blvd., Suite 406

Los Angeles, California 90015

Attention: Chief Executive Officer

Telecopy: (213) 765-9813

with a copy to:

Jonathan K. Layne

Gibson, Dunn & Crutcher LLP

2029 Century Park East

Los Angeles, California 90067

(b) if to Executive, to:

Brett R. Chapman

5054 Royal Vista Court

Thousand Oaks, California 91362

with a copy to:

Cathy J. Frankel, Esq.

Moses & Singer LLP

1301 Avenue of the Americas

New York, New York 10019-6076

or to such other place and with other copies as either party may designate as to itself or himself
by written notice to the others.

16. Counterparts. This Agreement may be executed in several counterparts, each of which
will be deemed to be an original, but all of which together shall constitute one and the same
Agreement.

17. Entire Agreement. The terms of this Agreement are intended by the parties to be the
final expression of their agreement with respect to the subject matter hereof and this Agreement
supersedes (and may not be contradicted by, modified or supplemented by) any prior or
contemporaneous agreement, written or oral, with respect thereto, including but not limited to the
Employment Agreement between the parties dated October 6, 2003 (which Employment Agreement shall be
deemed terminated as of the date of this Agreement), but with the exception of the Non-Statutory
Stock Option Agreement dated October 6, 2003, as amended effective as of December 30, 2003,
Non-Statutory Stock Option Agreement dated September 1, 2004, Stock Option Agreement dated December
1, 2004, Stock Option Agreement dated April 27, 2005, Stock Appreciation Right Award Agreement
dated March 23, 2006, Stock Unit Award Agreement dated March 23, 2006, Stock Unit Award Agreement
dated October 10, 2006, Shareholders’ Agreement dated July 31, 2002, and the Indemnification
Agreement. The parties further intend that this Agreement shall constitute the complete and
exclusive statement of its terms and that no extrinsic evidence whatsoever may be introduced in any
judicial, administrative, or other legal proceeding to vary the terms of this Agreement.

18. Amendments: Waivers. This Agreement may not be modified or amended except by an
instrument in writing, signed by Executive and a duly authorized representative of the Company. No
waiver of any of the provisions of this Agreement, whether by conduct or otherwise, in any one or
more instances, shall be deemed to be construed as a further, continuing, or subsequent waiver of
any such provision or as a waiver of any other provision of this Agreement. No failure to exercise
and no delay in exercising any right, remedy or power hereunder shall preclude any other or further
exercise of any other right, remedy, or power provided herein or by law or in equity.

19. Representation of Counsel; Mutual Negotiation. Each party has had the opportunity to
be represented by counsel of its choice in negotiating this Agreement. This Agreement shall
therefore be deemed to have been negotiated and prepared at the joint request, direction and
construction of the parties, at arm’s-length, with the advice and participation of counsel, and
shall be interpreted in accordance with its terms without favor to any party.

20. Surviving Terms. The provisions of Sections 4(a), 4 (b), 5, 6, 7, 8, 10 and 21 shall
survive the termination or expiration of this Agreement.

21. Compliance with Section 409A.

(a) The intent of the parties is that payments and benefits under this Agreement
comply with Section 409A of the Code and the regulations and guidance promulgated
thereunder (collectively “Section 409A”) and, accordingly, to the maximum extent
permitted, this Agreement shall be interpreted to be in compliance therewith. If
Executive notifies the Company (with reasonable specificity as to the reason
therefor) that Executive believes that any provision of this Agreement (or of any
award of compensation, including equity compensation or benefits) would cause
Executive to incur any additional tax or interest under Section 409A and the Company
concurs with such belief or the Company (without any obligation whatsoever to do so)
independently makes such determination, the Company shall, after consulting with
Executive, reform such provision to attempt to comply with Section 409A through good
faith modifications to the minimum extent reasonably appropriate to conform with
Section 409A. To the extent that any provision hereof is modified in order to
comply with Section 409A, such modification shall be made in good faith and shall,
to the maximum extent reasonably possible, maintain the original intent and economic
benefit/burden to Executive and the Company of the applicable provision without
violating the provisions of Section 409A.

(b) A termination of employment shall not be deemed to have occurred for purposes of
any provision of this Agreement providing for the payment of any amounts or benefits
upon or following a termination of employment unless such termination is also a
“separation from service” within the meaning of Section 409A and, for purposes of
any such provision of this Agreement, references to a “termination,” “termination of
employment” or like terms shall mean “separation from service.” If Executive is
deemed on the date of termination to be a “specified employee” within the meaning of
that term under Section 409A(a)(2)(B) of the Code, then with regard to any payment
or the provision of any benefit that is specified as subject to this Section or that
is otherwise considered deferred compensation under Section 409A payable on account
of a “separation from service,” and that is not exempt from Section 409A as
involuntary separation pay or a short-term deferral (or otherwise), such payment or
benefit shall be made or provided at the date which is the earlier of (i) the
expiration of the six (6)-month period measured from the date of such “separation
from service” of Executive, and (ii) the date of Executive’s death (the “Delay
Period”). Upon the expiration of the Delay Period, all payments and benefits
delayed pursuant to this Section 21(b) (whether they would have otherwise been
payable in a single sum or in installments in the absence of such delay) shall be
paid or reimbursed to Executive in a lump sum without interest, and any remaining
payments and benefits due under this Agreement shall be paid or provided in
accordance with the normal payment dates specified for them herein.

(c) With regard to any provision herein that provides for reimbursement of costs and
expenses or in-kind benefits, except as permitted by Section 409A, (i) the right to
reimbursement or in-kind benefits shall not be subject to liquidation or exchange
for another benefit, (ii) the amount of expenses eligible for reimbursement, or
in-kind benefits, provided during any taxable year shall not affect the expenses
eligible for reimbursement, or in-kind benefits to be provided, in any other taxable
year, provided that the foregoing clause (ii) shall not be violated without regard
to expenses reimbursed under any arrangement covered by Internal Revenue Code
Section 105(b) solely because such expenses are subject to a limit related to the
period the arrangement is in effect and (iii) such payments shall be made on or
before the last day of Executive’s taxable year following the taxable year in which
the expense occurred.

(d) Whenever a payment under this Agreement specifies a payment period with reference to a
number of days, the actual date of payment within the specified period shall be within the
sole discretion of the Company.

[signature page follows]

2

IN WITNESS WHEREOF, the parties have executed this Agreement as of the date and year first above
written.

EXECUTIVE

/s/ Brett R. Chapman

	 	 	By: Brett R. Chapman

HERBALIFE INTERNATIONAL OF AMERICA, INC.

/s/ Michael O. Johnson

By: Michael O. Johnson

Title: Chief Executive Officer

3

SCHEDULE A

Constitutional Rights FoundationATTACHMENT A

Agreement and General Release

Agreement and General Release (“AGREEMENT”), by and among BRETT R. CHAPMAN (“EXECUTIVE” and
referred to herein as “you”) and HERBALIFE INTERNATIONAL OF AMERICA, INC., a California corporation
(the “COMPANY”).

1. In exchange for your waiver of claims against the Company Entities (as defined below) and
compliance with other terms and conditions of this Agreement, upon the effectiveness of this
Agreement, the Company agrees to provide you with the payments and benefits provided in Section 4
of your Amended and Restated Employment Agreement with the Company.

2. (a) In consideration for the payments and benefits to be provided to you pursuant to paragraph 1
above, you, for yourself and for your heirs, executors, administrators, trustees, legal
representatives, and assigns (hereinafter referred to collectively as “RELEASORS”), FOREVER RELEASE
AND DISCHARGE THE Company and its past, present and future parent entities, subsidiaries,
divisions, affiliates and related business entities, successors and assigns, assets, employee
benefit plans or funds (including, without limitation, each of Whitney & Co., LLC, Golden Gate
Private Equity, Inc., any investment fund managed by either of them and any affiliate of any of the
aforementioned persons or entities), and any of its or their respective past, present and/or future
directors, officers, fiduciaries, agents, trustees, administrators, employees and assigns, whether
acting on behalf of the Company or in their individual capacities (collectively the “COMPANY
ENTITIES”) from any and all claims, suits, demands, causes of action, covenants, obligations,
debts, costs, expenses, fees and liabilities of any kind whatsoever in law or equity, by statute or
otherwise, whether known or unknown, vested or contingent, suspected or unsuspected and whether or
not concealed or hidden (collectively, the “CLAIMS”), which you ever had, now have, or may have
against any of the Company Entities by reason of any act, omission, transaction, practice, plan,
policy, procedure, conduct, occurrence, or other matter related in any way to your employment by
(including, but not limited to, termination thereof) the Company Entities up to and including the
date on which you sign this Agreement, except as provided in subsection (c) below.

(b) Without limiting the generality of the foregoing, this Agreement is intended to and shall
release the Company Entities from any and all claims, whether known or unknown, which Releasors
ever had, now have, or may have against the Companies Entities arising out of your employment or
termination thereof, including, but not limited to: (i) any claim under the Age Discrimination in
Employment Act, Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act, the
Employee Retirement Income Security Act of 1974,(excluding claims for accrued, vested benefits
under any employee benefit or pension plan of the Company Entities subject to the terms and
conditions of such plan and applicable law), the Family and Medical Leave Act, the Worker
Adjustment and Retraining Notification Act of 1988, or the Fair Labor Standards Act of 1938, in
each case as amended; (ii) any claim under the California Fair Employment and Housing Act, the
California Labor Code, the California Family Rights Act, or the California pregnancy Disability
Leave Law; (iii) any other claim (whether based on federal, state, or local law (statutory or
decisional), rule, regulation or ordinance) relating to or arising out of your employment, the
terms and conditions of such employment, the termination of such employment, including, but not
limited to, breach of contract (express or implied), wrongful discharge, detrimental reliance,
defamation, emotional distress or compensatory or punitive damages; and (iv) any claim for
attorneys’ fees, costs, disbursements and/or the like.

(c) Notwithstanding the foregoing, nothing in this Agreement shall be a waiver of claims: (1)
that may arise after the date on which you sign this Agreement; (2) with respect to your right to
enforce your rights that survive termination under the Amended and Restated Employment Agreement or
any other written agreement entered into between you and the Company (including, without
limitation, any agreements granting you any stock units, stock appreciation rights, stock options
or any other equity grants or equivalents); (3) regarding rights of indemnification, receipt of
legal fees and directors and officers liability insurance to which you are entitled under the
Amended and Restated Employment Agreement, the Company’s Certificate of Incorporation or By-laws,
pursuant to any separate writing between you and the Company or pursuant to applicable law; (4)
relating to any claims for accrued, vested benefits under any employee benefit plan or pension plan
of the Company Entities subject to the terms and conditions of such plan and applicable law; or (5)
as a stockholder or optionholder of the Company.

(d) In signing this Agreement, you acknowledge that you intend that this Agreement shall be
effective as a bar to each and every one of the Claims hereinabove mentioned or implied. You
expressly consent that this Agreement shall be given full force and effect according to each and
all of its express terms and provisions, including those relating to unknown, unsuspected or
unanticipated Claims (notwithstanding any state statute that expressly limits the effectiveness of
a general release of unknown, unsuspected or unanticipated Claims), if any, as well as those
relating to any other claims hereinabove mentioned or implied. You acknowledge and agree that this
waiver is an essential and material term of this Agreement, and if you bring your own Claim in
which you seek damages against any Company Entity, or if you seek to recover against any Company
Entity in any Claim brought by a governmental agency on your behalf, the release set forth in this
Agreement shall serve as a complete defense to such Claims, and you shall reimburse each Company
Entity for any attorneys’ fees or expense or other fees and expense incurred in defending such
Claim; provided, however, if a class action claim or governmental claim is brought on your behalf,
your obligations will be limited to (i) opting out of such action or other proceedings received in
connection therewith to the Company, it being agreed that you shall not be liable to the Company
for any attorneys’ fees or expense or other fees or expenses in the case of any such class action
claim or governmental claim.

(e) Without limiting the generality of the foregoing, you waive all rights under California
Civil Code Section 1542, which provides:

A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO
EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM OR HER
MUST HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR.

3. (a) This Agreement is not intended, and shall not be construed, as an admission that any of the
Company Entities has violated any federal, state or local law (statutory or decisional), ordinance
or regulation, breached any contract or committed any wrong whatsoever against you.

(b) Should any provision of this Agreement require interpretation or construction, it is
agreed by the parties that the entity interpreting or constructing this Agreement shall not apply a
presumption against one party by reason of the rule of construction that a document is to be
construed more strictly against the party who prepared the document.

4. For two years from and after the date of your employment termination, you agree not to make any
derogatory, negative or disparaging public statement about any Company Entity, or to make any
public statement (or any statement likely to become public) that could reasonably be expected to
adversely affect or disparage the reputation, or, to the extent applicable, business or goodwill of
any Company Entity, it being agreed and understood that nothing herein shall prohibit you (a) from
disclosing that you are no longer employed by the Company, (b) from responding truthfully to any
governmental investigation or inquiry related thereto, whether by the Securities and Exchange
Commission or other governmental entity or any other law, subpoena, court order or other compulsory
legal process or any disclosure requirement of the Securities and Exchange Commission, or (c) from
making traditional competitive statements in the course of promoting a competing business, so long
as any statements made by you described in this clause (c) are not based on confidential
information obtained during the course of your employment with the Company. The Company agrees that
it will not make any derogatory, negative or disparaging public statement about you in an
authorized press release or authorized public announcement.

5. This Agreement is binding upon, and shall inure to the benefit of, the parties and their
respective heirs, executors, administrators, successors and assigns.

6. This Agreement shall be construed and enforced in accordance with the laws of the State of
California applicable to agreements made and to be performed entirely within such State.

7. You acknowledge that your obligations pursuant to Sections 6, 7 and 8 of the Amended and
Restated Employment Agreement survive the termination of your employment in accordance with the
terms thereof. The Company acknowledges that its obligations under Sections 4(a), 4(b), 5, 8, 10
and 21 of the Amended and Restated Employment Agreement survive the termination of your employment
in accordance with the terms thereof.

8. You acknowledge that you: (a) have carefully read this Agreement in its entirety; (b) have had
an opportunity to consider for at least twenty-one (21) days the terms of this Agreement; (c) are
hereby advised by the Company in writing to consult with an attorney of your choice in connection
with this Agreement; (d) fully understand the significance of all of the terms and conditions of
this Agreement and have discussed them with your independent legal counsel, or have had a
reasonable opportunity to do so; (e) have had answered to your satisfaction by your independent
legal counsel any questions you have asked with regard to the meaning and significance of any of
the provisions of this Agreement; and (f) are signing this Agreement voluntarily and of your own
free will and agree to abide by all the terms and conditions contained herein.

9. You understand that you will have at least twenty-one (21) days from the date of receipt of this
Agreement to consider the terms and conditions of this Agreement. You may accept this Agreement by
signing it and returning it to the Company’s Chief Executive Officer at the address specified
pursuant to Section 15 of the Amended and Restated Employment Agreement. After executing this
Agreement, you shall have seven (7) days (the “REVOCATION PERIOD”) to revoke this Agreement by
indicating your desire to do so in writing delivered to the Chief Executive Officer at the address
above by no later than 5:00 p.m. on the seventh (7th) day after the date you sign this Agreement.
The effective date of this Agreement shall be the eighth (8th) day after you sign the Agreement
(the “AGREEMENT EFFECTIVE DATE”). If the last day of the Revocation Period falls on a Saturday,
Sunday or holiday, the last day of the Revocation Period will be deemed to be the next business
day. In the event you do not accept this Agreement as set forth above, or in the event you revoke
this Agreement during the Revocation Period, this Agreement, including but not limited to the
obligation of the Company to provide the payments and benefits provided in paragraph 1 above, shall
be deemed automatically null and void.

EXECUTIVE

By:

Brett R. Chapman

HERBALIFE INTERNATIONAL OF AMERICA, INC.

By:

Name:

Title:

4EX-10.1

EXHIBIT 10.1

NRG ENERGY, INC.

AMENDED AND RESTATED LONG-TERM INCENTIVE PLAN

(As Amended and Restated April 29, 2010)

(As Approved by Shareholders July 28, 2010)

	1.	 	Purpose.

This plan shall be known as the NRG Energy, Inc. Long-Term Incentive Plan (the
“Plan”). The purpose of the Plan shall be to promote the long-term growth and
profitability of NRG Energy, Inc., a Delaware corporation (the “Company”), and its
Subsidiaries by (i) providing certain directors, officers and employees of, and certain other
individuals who perform services for, or to whom an offer of employment has been extended by, the
Company and its Subsidiaries with incentives to maximize shareholder value and otherwise contribute
to the success of the Company and (ii) enabling the Company to attract, retain and reward the best
available persons for positions of responsibility. Grants of Incentive Stock Options or
Non-qualified Stock Options, stock appreciation rights (“SARs”), either alone or in tandem
with options, restricted stock, restricted stock units, performance awards, deferred stock units or
any combination of the foregoing (collectively, the “Awards”) may be made under the Plan.
Notwithstanding any provision of the Plan, to the extent that any Award would be subject to Section
409A of the Code, no such Award may be granted if it would fail to comply with the requirements set
forth in Section 409A of the Code and any regulations or guidance promulgated thereunder.

	2.	 	Definitions.

(a) “Board” means the board of directors of the Company.

(b) “Cause”, unless otherwise defined in a Participant’s Grant Agreement or in a
Participant’s written employment arrangements with the Company or any of its Subsidiaries in effect
on the date of grant (as amended from time to time thereafter), means the occurrence of one or more
of the following events:

(i) Conviction of, or agreement to a plea of nolo contendere to, a felony, or any crime or
offense lesser than a felony involving the property of the Company or a Subsidiary; or

(ii) Conduct that has caused demonstrable and serious injury to the Company or a Subsidiary,
monetary or otherwise; or

(iii) Willful refusal to perform or substantial disregard of duties properly assigned, as
determined by the Company; or

(iv) Breach of duty of loyalty to the Company or a Subsidiary or other act of fraud or
dishonesty with respect to the Company or a Subsidiary; or

(v) Violation of the Company’s code of conduct.

The definition of Cause set forth in a Participant’s Grant Agreement shall control if such
definition is different from the definition of Cause set forth in a Participant’s written
employment arrangements with the Company or any of its Subsidiaries.

(c) “Change in Control”, unless otherwise defined in a Participant’s Grant Agreement,
means the occurrence of one of the following events:

(i) Any “person” (as that term is used in Sections 13 and 14(d)(2) of the Exchange Act or any
successors thereto) becomes the “beneficial owner” (as that term is used in Section 13(d) of the
Exchange Act or any successor thereto), directly or indirectly, of 50% or more of the Company’s
capital stock entitled to vote in the election of directors, excluding any “person” who becomes a
“beneficial owner” in connection with a Business Combination (as defined in paragraph (iii) below)
which does not constitute a Change in Control under said paragraph (iii); or

(ii) Persons who on the effective date of the plan of reorganization of the Company (the
“Commencement Date”) constitute the Board (the “Incumbent Directors”) cease for any
reason, including without limitation, as a result of a tender offer, proxy contest, merger or
similar transaction, to constitute at least a majority thereof; provided that, any person becoming
a director of the Company subsequent to the Commencement Date shall be considered an Incumbent
Director if such person’s election or nomination for election was approved by a vote of at least
two-thirds (2/3) of the Incumbent Directors; but provided further that, any such person whose
initial assumption of office is in connection with an actual or threatened election contest
relating to the election of members of the Board or other actual or threatened solicitation of
proxies or consents by or on behalf of a “person” (as defined in Sections 13(d) and 14(d) of the
Exchange Act) other than the Board, including by reason of agreement intended to avoid or settle
any such actual or threatened contest or solicitation, shall not be considered an Incumbent
Director; or

(iii) Consummation of a reorganization, merger or consolidation or sale or other disposition
of all or substantially all of the assets of the Company (a “Business Combination”), in
each case, unless, following such Business Combination, all or substantially all of the individuals
and entities who were the beneficial owners of outstanding voting securities of the Company
immediately prior to such Business Combination beneficially own, directly or indirectly, more than
50% of the combined voting power of the then outstanding voting securities entitled to vote
generally in the election of directors, as the case may be, of the company resulting from such
Business Combination (including, without limitation, a company which, as a result of such
transaction, owns the Company or all or substantially all of the Company’s assets either directly
or through one or more subsidiaries) in substantially the same proportions as their ownership,
immediately prior to such Business Combination, of the outstanding voting securities of the
Company; or

(iv) The shareholders of the Company approve any plan or proposal for the liquidation or
dissolution of the Company.

(d) “Code” means the Internal Revenue Code of 1986, as amended.

(e) “Committee” means the Compensation Committee of the Board or such other committee
which shall consist solely of two or more members of the Board, each of whom is (i) an “outside
director” within the meaning of Treasury Regulation §1.162-27(e)(3); (ii) a non-employee director
under Rule 16b-3 of the Exchange Act and (iii) an “independent director” under the rules of any
national securities exchange on which the Common Stock is listed for trading; provided that, if for
any reason the Committee shall not have been appointed by the Board to administer the Plan, all
authority and duties of the Committee under the Plan shall be vested in and exercised by the Board,
and the term “Committee” shall be deemed to mean the Board for all purposes herein.

(f) “Common Stock” means the Common Stock, par value $0.01 per share, of the Company,
and any other shares into which such stock may be changed by reason of a recapitalization,
reorganization, merger, consolidation or any other change in the corporate structure or capital
stock of the Company.

(g) “Disability”, unless otherwise defined in a Participant’s Grant Agreement, means a
disability that would entitle an eligible Participant to payment of monthly disability payments
under any Company long-term disability plan or as otherwise determined by the Committee.

(h) “Exchange Act” means the Securities Exchange Act of 1934, as amended.

(i) “Fair Market Value” of a share of Common Stock of the Company means, as of the
date in question, and except as otherwise provided in any Grant Agreement entered into pursuant to
agreements in effect as of the Commencement Date, the officially-quoted closing selling price of
the stock (or if no selling price is quoted, the bid price) on the principal securities exchange on
which the Common Stock is then listed for trading (including for this purpose the Nasdaq National
Market) (the “Market”) for the applicable trading day (or if there no closing price on such
day because the Market is not open on such day, the last preceding day on which the Market was
open) or, if the Common Stock is not then listed or quoted in the Market, the Fair Market Value
shall be the fair value of the Common Stock determined in good faith by the Board and, in the case
of an Incentive Stock Option, in accordance with Section 422 of the Code; provided, however, that
when shares received upon exercise of an option are immediately sold in the open market, the net
sale price received may be used to determine the Fair Market Value of any shares used to pay the
exercise price or applicable withholding taxes and to compute the withholding taxes.

(j) “Family Member” has the meaning given to such term in General Instructions
A.1(a)(5) to Form S-8 under the Securities Act of 1933, as amended, and any successor thereto.

(k) “Grant Agreement” means the written (whether in print or electronic form)
agreement that each Participant to whom an Award is made under the Plan is required to enter into
with the Company containing the terms and conditions of such grant as are determined by the
Committee and consistent with the Plan.

(l) “Incentive Stock Option” means an option conforming to the requirements of Section
422 of the Code and any successor thereto.

(m) “Non-qualified Stock Option” means any stock option other than an Incentive Stock
Option.

(n) “Participant” means any director, officer or employee of, or other individual
performing services for, or to whom an offer of employment has been extended by, the Company or any
Subsidiary who has been selected by the Committee to participate in the Plan (including a
Participant located outside the United States).

(o) “Retirement”, (i) for any non-director, unless otherwise determined by the
Committee, means (A) termination of service as a non-director after at least 10 years of service by
such non-director and (B) attaining at least 55 years of age, and (ii) for any director,
unless otherwise determined by the Committee, means termination of service as a director after at
least five years of Board service by such director.

(p) “Subsidiary” means a corporation or other entity of which outstanding shares or
ownership interests representing 50% or more of the combined voting power of such corporation or
other entity entitled to elect the management thereof, or such lesser percentage as may be approved
by the Committee, are owned directly or indirectly by the Company.

	3.	 	Administration.

The Plan shall be administered by the Committee. In no event, however, shall the Committee
modify the distribution terms in any Award or Grant Agreement that has a feature for the deferral
of compensation if such modification would result in taxes, additional interest and/or penalties
pursuant to Code Section 409A. Subject to the provisions of the Plan, the Committee shall be
authorized to (i) select persons to participate in the Plan, (ii) determine the form and substance
of grants made under the Plan to each Participant, and the conditions and restrictions, if any,
subject to which such grants will be made, (iii) determine the form and substance of the Grant
Agreements reflecting the terms and conditions of each grant made under the Plan, (iv) certify that
the conditions and restrictions applicable to any grant have been met, (v) modify the terms of
grants made under the Plan, (vi) interpret the Plan and Grant Agreements entered into under the
Plan, (vii) determine the duration and purposes for leaves of absence which may be granted to a
Participant on an individual basis without constituting a termination of employment or services for
purposes of the Plan, (viii) make any adjustments necessary or desirable in connection with grants
made under the Plan to eligible Participants located outside the United States, (ix) adopt, amend,
or rescind rules and regulations for the administration of the Plan, including, but not limited to,
correcting any defect or supplying any omission, or reconciling any inconsistency in the Plan or in
any Grant Agreement, in the manner and to the extent it shall deem necessary or advisable,
including so that the Plan and the operation of the Plan complies with Rule 16b-3 under the
Exchange Act, the Code to the extent applicable and other applicable law and make such other
determinations for carrying out the Plan as it may deem appropriate, and (x) exercise such powers
and perform such acts as are deemed necessary or advisable to promote the best interests of the
Company with respect to the Plan. Notwithstanding the foregoing, the Committee shall not take any
of the following actions without shareholder approval, except as provided in Section 17:
(i) reduce the exercise price following the grant of an option or SAR; (ii) exchange an option or
SAR which has an exercise price that is greater than the Fair Market Value of a Share for cash or
Shares or (iii) cancel an option or SAR in exchange for a replacement option or another Award with
a lower exercise price. Decisions of the Committee on all matters relating to the Plan, any Award
granted under the Plan and any Grant Agreement shall be in the Committee’s sole discretion and
shall be conclusive and binding on the Company, all Participants and all other parties, unless an
arbitration or other provision is expressly provided in a Participant’s Grant Agreement. The
validity, construction, and effect of the Plan and any rules and regulations relating to the Plan
shall be determined in accordance with applicable federal and state laws and rules and regulations
promulgated pursuant thereto. No member of the Committee and no officer of the Company shall be
liable for any action taken or omitted to be taken by such member, by any other member of the
Committee or by any officer of the Company in connection with the performance of duties under the
Plan, except for such person’s own willful misconduct or as expressly provided by statute.

The expenses of the Plan shall be borne by the Company. The Plan shall not be required to
establish any special or separate fund or make any other segregation of assets to assume the
payment of any Award under the Plan, and rights to the payment of such Awards shall be no greater
than the rights of the Company’s general creditors.

	4.	 	Shares Available for the Plan.

Subject to adjustments as provided in Section 17, an aggregate of 22,000,000 shares of
Common Stock (the “Shares”) may be issued pursuant to the Plan. Such Shares may be in
whole or in part authorized and unissued or held by the Company as treasury shares. If any grant
under the Plan expires or terminates unexercised, becomes unexercisable or is forfeited as to any
Shares, or is tendered or withheld as to any Shares in payment of the exercise price of the grant
or the taxes payable with respect to the exercise, then such unpurchased, forfeited, tendered or
withheld Shares shall thereafter be available for further grants under the Plan unless, in the case
of options granted under the Plan, related SARs are exercised. With respect to SARs that are
settled in Common Stock, upon settlement, only the number of shares of Common Stock delivered to a
Participant upon the exercise of the SARs shall count against the number of Shares issued under the
Plan. Any Award under the Plan settled in cash shall not be counted against the foregoing maximum
share limitations. The maximum number of shares with respect to which Incentive Stock Options may
be granted shall be 8,000,000. Shares issued under Awards granted in assumption, substitution or
exchange for previously granted awards of a company acquired by the Company (“Substitute
Awards”) shall not reduce Shares available under Plan. Available shares under a stockholder
approved plan of an acquired company (as appropriately adjusted to reflect such acquisition) may be
used for Awards under this Plan and shall not reduce the number of Shares available under this
Plan, except as required by the rules of any applicable stock exchange.

Without limiting the generality of the foregoing provisions of this Section 4 or the
generality of the provisions of Sections 3, 6, 7, 8, 9, 10, or 19 or any other
section of this Plan, the Committee may, at any time or from time to time, and on such terms and
conditions (that are consistent with and not in contravention of the other provisions of this Plan)
as the Committee may determine, enter into Grant Agreements (or take other actions with respect to
the Awards) for new Awards containing terms (including, without limitation, exercise prices) more
(or less) favorable than the then-outstanding Awards.

	5.	 	Participation.

Participation in the Plan shall be limited to the Participants. Nothing in the Plan or in any
Grant Agreement shall confer any right on a Participant to continue in the employ of the Company or
any Subsidiary as a director, officer or employee of or in the performance of services for the
Company or shall interfere in any way with the right of the Company to terminate the employment or
performance of services or to reduce the compensation or responsibilities of a Participant at any
time. By accepting any Award under the Plan, each Participant and each person claiming under or
through him or her shall be conclusively deemed to have indicated his or her acceptance and
ratification of, and consent to, any action taken under the Plan by the Company, the Board or the
Committee.

Awards may be granted to such persons and for such number of Shares as the Committee shall
determine, subject to the limitations contained herein (such individuals to whom grants are made
being sometimes herein called “optionees” or “grantees,” as the case may be). Determinations made
by the Committee under the Plan need not be uniform and may be made selectively among eligible
individuals under the Plan, whether or not such individuals are similarly situated. A grant of any
type made hereunder in any one year to an eligible Participant shall neither guarantee nor preclude
a further grant of that or any other type to such Participant in that year or subsequent years.

	6.	 	Incentive and Non-qualified Options.

The Committee may from time to time grant to eligible Participants Incentive Stock Options,
Non-qualified Stock Options, or any combination thereof; provided that, the Committee may grant
Incentive Stock Options only to eligible employees of the Company or its Subsidiaries (as defined
for this purpose in Section 424(f) of the Code or any successor thereto). In any one calendar
year, the Committee shall not grant to any one Participant options to purchase a number of Shares
of Common Stock in excess of 1,000,000 shares of Common Stock. The options granted under the Plan
shall be evidenced by a Grant Agreement and shall take such form as the Committee shall determine,
subject to the terms and conditions of the Plan.

It is the Company’s intent that Non-qualified Stock Options granted under the Plan not be
classified as Incentive Stock Options, that Incentive Stock Options be consistent with and contain
or be deemed to contain all provisions required under Section 422 of the Code and any successor
thereto, and that any ambiguities in construction be interpreted in order to effectuate such
intent. If an Incentive Stock Option granted under the Plan does not qualify as such for any
reason, then to the extent of such non-qualification, the stock option represented thereby shall be
regarded as a Non-qualified Stock Option duly granted under the Plan; provided that, such stock
option otherwise meets the Plan’s requirements for Non-qualified Stock Options.

(a) Price. The price per Share deliverable upon the exercise of each option (the
“exercise price”) shall be established by the Committee, except that in the case of the
grant of any option, the exercise price may not be less than 100% of the Fair Market Value of a
share of Common Stock as of the date of grant of the option except for Substitute Awards, which
shall have the exercise price as determined by the Committee provided that such exercise price does
not cause the Substitute Award to become subject to Code Section 409A and the Committee takes into
consideration any third-party voting guidelines. In the case of the grant of any Incentive Stock
Option to an employee who, at the time of the grant, owns more than 10% of the total combined
voting power of all classes of stock of the Company or any of its Subsidiaries, the exercise price
may not be less than 110% of the Fair Market Value of a share of Common Stock as of the date of
grant of the option, in each case unless otherwise permitted by Section 422 of the Code or any
successor thereto.

(b) Payment. Options may be exercised, in whole or in part, upon payment of the
exercise price of the Shares to be acquired. Unless otherwise determined by the Committee, payment
shall be made (i) in cash (including check, bank draft, money order or wire transfer of immediately
available funds), (ii) by delivery of outstanding shares of Common Stock with a Fair Market Value
on the date of exercise equal to the aggregate exercise price payable with respect to the options’
exercise, (iii) by means of any cashless exercise procedures approved by the Committee and as may
be in effect on the date of exercise, (iv) by withholding shares of Common Stock otherwise
deliverable upon exercise of the Option having a Fair Market Value equal to the exercise price or
(v) by any combination of the foregoing.

In the event a grantee is permitted to, and elects to pay the exercise price payable with
respect to an option pursuant to clause (ii) above, (A) only a whole number of share(s) of Common
Stock (and not fractional shares of Common Stock) may be tendered in payment, (B) such grantee must
present evidence acceptable to the Company that he or she has owned any such shares of Common Stock
tendered in payment of the exercise price (and that such tendered shares of Common Stock have not
been subject to any substantial risk of forfeiture) for at least six months prior to the date of
exercise or such longer period as determined from time to time by the Committee, and (C) Common
Stock must be delivered to the Company. Delivery for this purpose may, at the election of the
grantee, be made either by (A) physical delivery of the certificate(s) for all such shares of
Common Stock tendered in payment of the exercise price, accompanied by duly executed instruments of
transfer in a form acceptable to the Company, (B) direction to the grantee’s broker to transfer, by
book entry, such shares of Common Stock from a brokerage account of the grantee to a brokerage
account specified by the Company, or (C) the attestation of the grantee’s shares of Common Stock.
When payment of the exercise price is made by delivery of Common Stock, the difference, if any,
between the aggregate exercise price payable with respect to the option being exercised and the
Fair Market Value of the shares of Common Stock tendered in payment (plus any applicable taxes)
shall be paid in cash. No grantee may tender shares of Common Stock having a Fair Market Value
exceeding the aggregate exercise price payable with respect to the option being exercised (plus any
applicable taxes).

(c) Terms of Options. The term during which each option may be exercised shall be
determined by the Committee, but if required by the Code, no option shall be exercisable in whole
or in part more than ten years from the date it is granted, and no Incentive Stock Option granted
to an employee who at the time of the grant owns more than 10% of the total combined voting power
of all classes of stock of the Company or any of its Subsidiaries shall be exercisable more than
five years from the date it is granted. All rights to purchase Shares pursuant to an option shall,
unless sooner terminated, expire on the date designated by the Committee. The Committee shall
determine the date on which each option shall become exercisable and may provide that an option
shall become exercisable in installments. The Committee may provide that upon the last day of the
term of an Option whose exercise price is less than the fair market value of the underlying Share
on such date, such Option may be automatically exercised and the Participant shall receive a number
of Shares equal in value to the excess of the fair market value of a Share over the exercise price
of such Option, less any applicable withholding taxes. The Shares constituting each installment
may be purchased in whole or in part at any time after such installment becomes exercisable,
subject to such minimum exercise requirements as may be designated by the Committee. Prior to the
exercise of an option and delivery of the Shares represented thereby, the optionee shall have no
rights as a shareholder with respect to any Shares covered by such outstanding option (including
any dividend or voting rights). If an Option (other than an Incentive Stock Option) expires on a
day that the Participant cannot exercise the Option because such an exercise would violate an
applicable federal, state, local, or foreign law, the expiration date shall be tolled, at the
discretion of the Committee, to the date no later than 30 days after the date the exercise of such
Option would no longer violate an applicable Federal, state, local, and foreign laws, to the extent
allowed under Code Section 409A.

(d) Limitations on Grants. If required by the Code, the aggregate Fair Market Value
(determined as of the grant date) of Shares for which an Incentive Stock Option is exercisable for
the first time during any calendar year under all equity incentive plans of the Company and its
Subsidiaries (as defined in Section 422 of the Code or any successor thereto) may not exceed
$100,000.

(e) Termination; Forfeiture.

(i) Death. Unless otherwise provided in a Participant’s Grant Agreement, if a
Participant ceases to be a director, officer or employee of, or to perform other services for, the
Company or any Subsidiary due to his or her death, all of the Participant’s Awards shall become
fully vested and all of the Participant’s options shall become exercisable and shall remain so for
a period of one year from the date of such death, but in no event after the expiration date of the
options.

(ii) Disability. Unless otherwise provided in a Participant’s Grant Agreement, if a
Participant ceases to be a director, officer or employee of, or to perform other services for, the
Company or any Subsidiary due to Disability, (A) all of the Participant’s options that were
exercisable on the date of Disability shall remain exercisable for, and shall otherwise terminate
and thereafter be forfeited at the end of, a period of one year after the date of Disability, but
in no event after the expiration date of the options, and (B) all of the Participant’s Awards that
were not fully vested (or, with respect to the Participant’s options, exercisable) on the date of
Disability shall be forfeited immediately upon such Disability; provided, however, that such Awards
may become fully vested (and, with respect to the Participant’s options, exercisable) in the
discretion of the Committee. Notwithstanding the foregoing, if the Disability giving rise to the
termination of employment is not within the meaning of Section 22(e)(3) of the Code or any
successor thereto, Incentive Stock Options not exercised by such Participant within 90 days after
the date of termination of employment will cease to qualify as Incentive Stock Options and will be
treated as Non-qualified Stock Options under the Plan if required to be so treated under the Code.

(iii) Retirement. Unless otherwise provided in a Participant’s Grant Agreement, if a
Participant ceases to be an officer or employee of, or to perform other services for, the Company
or any Subsidiary upon the occurrence of his or her Retirement, (A) all of the Participant’s
options that were exercisable on the date of Retirement shall remain exercisable for, and shall
otherwise terminate and thereafter be forfeited at the end of, a period of two years after the date
of Retirement, but in no event after the expiration date of the options, and (B) all of the
Participant’s Awards that were not fully vested (or, with respect to the Participant’s options,
exercisable) on the date of Retirement shall be forfeited immediately upon such Retirement;
provided, however, that such Awards may become fully vested (and, with respect to the Participant’s
options, exercisable) in the discretion of the Committee. Notwithstanding the foregoing, Incentive
Stock Options not exercised by such Participant within 90 days after Retirement will cease to
qualify as Incentive Stock Options and will be treated as Non-qualified Stock Options under the
Plan if required to be so treated under the Code.

Unless otherwise provided in a Participant’s Grant Agreement, if a Participant ceases to be a
director of the Company or any Subsidiary upon the occurrence of his or her Retirement, all of the
Participant’s Awards shall become fully vested and all of the Participant’s options shall become
exercisable and shall remain so for a period of two years after the date of Retirement, but in no
event after the expiration date of the options.

(iv) Discharge for Cause. Unless otherwise provided in a Participant’s Grant
Agreement, if a Participant ceases to be a director, officer or employee of, or to perform other
services for, the Company or a Subsidiary due to Cause, or if a Participant does not become a
director, officer or employee of, or does not begin performing other services for, the Company or a
Subsidiary for any reason, all of the Participant’s Awards shall be forfeited immediately and all
of the Participant’s options shall expire and be forfeited immediately, whether or not then
exercisable, upon such cessation or non-commencement.

(v) Other Termination. If a Participant ceases to be a director, officer or employee
of, or to otherwise perform services for, the Company or a Subsidiary for any reason other than
death, Disability, Retirement or Cause (each such termination referred to as an “Other
Termination”), (A) all of the Participant’s options that were exercisable on the date of such
cessation shall remain exercisable for, and shall otherwise terminate and thereafter be forfeited
at the end of, a period of 90 days after the date of such cessation, but in no event after the
expiration date of the options, and (B) all of the Participant’s Awards that were not fully vested
(or, with respect to the Participant’s options, exercisable) on the date of such cessation shall be
forfeited immediately upon such cessation. For the avoidance of doubt, an Other Termination with
recall rights shall be considered an Other Termination to which this Section 6.e.(v)
applies.

	7.	 	Stock Appreciation Rights.

The Committee shall have the authority to grant SARs under this Plan, either alone or to any
optionee in tandem with options (either at the time of grant of the related option or thereafter by
amendment to an outstanding option). SARs shall be subject to such terms and conditions as the
Committee may specify. In any one calendar year, the Committee shall not grant to any one
Participant SARs with respect to a number of Shares of Common Stock in excess of 1,000,000 shares
of Common Stock.

The exercise price of an SAR must equal or exceed the Fair Market Value of a share of Common
Stock on the date of grant of the SAR except for Substitute Awards, which shall have the exercise
price as determined by the Committee provided that such exercise price does not cause the
Substitute Award to become subject to Code Section 409A and the Committee takes into consideration
any third-party voting guidelines. Prior to the exercise of the SAR and delivery of the Shares
represented thereby, the Participant shall have no rights as a shareholder with respect to Shares
covered by such outstanding SAR (including any dividend or voting rights).

SARs granted in tandem with options shall be exercisable only when, to the extent and on the
conditions that any related option is exercisable. The exercise of an option shall result in an
immediate forfeiture of any related SAR to the extent the option is exercised, and the exercise of
an SAR shall cause an immediate forfeiture of any related option to the extent the SAR is
exercised.

Upon the exercise of an SAR, the Participant shall be entitled to a distribution from the
Company in an amount equal to the difference between the Fair Market Value of a share of Common
Stock on the date of exercise and the exercise price of the SAR or, in the case of SARs granted in
tandem with options, any option to which the SAR is related, multiplied by the number of Shares as
to which the SAR is exercised. Such distribution shall be in cash and/or Shares having a Fair
Market Value equal to such amount, or any combination thereof as chosen by the Committee.

All SARs will be exercised automatically on the last day prior to the expiration date of the
SAR or, in the case of SARs granted in tandem with options, any related option, so long as the Fair
Market Value of a share of Common Stock on that date exceeds the exercise price of the SAR or any
related option, as applicable. An SAR granted in tandem with options shall expire at the same time
as any related option expires and shall be transferable only when, and under the same conditions
as, any related option is transferable. Unless otherwise determined by a Participant’s Grant
Agreement, each SAR shall be subject to the termination and forfeiture provisions as set forth in
Section 6.e.

	8.	 	Restricted Stock; Restricted Stock Units.

The Committee may at any time and from time to time grant Shares of restricted stock or
restricted stock units under the Plan to such Participants and in such amounts as it determines.
Each restricted stock unit shall be equivalent in value to one share of Common Stock and shall
entitle the Participant to receive from the Company at the end of the vesting period (the “Vesting
Period”) applicable to such unit the Fair Market Value of one share of Common Stock, unless the
Participant has elected at a time that complies with Code Section 409A to defer the receipt of
shares of Common Stock.

Each grant of restricted stock units or Shares of restricted stock shall be evidenced by a
Grant Agreement which shall specify the applicable restrictions on such units or Shares, the
duration of such restrictions, and the time or times at which such restrictions shall lapse with
respect to all or a specified number of units or Shares that are part of the grant; provided,
however, except for maximum aggregate Awards of restricted stock or restricted stock units of 5% of
the aggregate Shares authorized by Section 4, if the vesting condition for any Award, other
than an Incentive Stock Option or Non-qualified Stock Option, that is settled in Common Stock
(including Awards of restricted stock and restricted stock units)(a “Full Value Award”), relates
(x) exclusively to the passage of time and continued employment, such time period shall not be less
than 36 months, with thirty-three and one-third percent (33?%) of the Award vesting every 12 months
from the date of the Award, subject to Section 6.e. and (y) to the attainment of specified
performance goals, such Full Value Award shall vest over a performance period of not less than one
(1) year. Except for maximum aggregate Awards of restricted stock or restricted stock units of 5%
of the aggregate Shares authorized by Section 4, the Committee shall not waive or modify
any vesting condition for a Full Value Award after such vesting condition has been established with
respect to such Award.

Except as otherwise provided in any Grant Agreement, the Participant will be required to pay
the Company the aggregate par value of any Shares of restricted stock within ten days of the date
of grant, unless such Shares of restricted stock are treasury shares. Unless otherwise determined
by the Committee, certificates representing Shares of restricted stock granted under the Plan will
be held in escrow by the Company on the Participant’s behalf during any period of restriction
thereon and will bear an appropriate legend specifying the applicable restrictions thereon, and the
Participant will be required to execute a blank stock power therefor.

Restricted stock units may be granted without payment of cash or consideration to the Company.
Except as otherwise provided in any Grant Agreement, on the date the restricted stock units become
fully vested and nonforfeitable, the Participant shall receive, upon payment by the Participant to
the Company of the aggregate par value of the shares of Common Stock underlying each fully vested
restricted stock unit, stock certificates evidencing the conversion of restricted stock units into
shares of Common Stock.

Except as otherwise provided in any Grant Agreement, with respect to Shares of restricted
stock, during such period of restriction the Participant shall have all of the rights of a holder
of Common Stock, including but not limited to the rights to receive dividends and to vote, and any
stock or other securities received as a distribution with respect to such Participant’s Shares of
restricted stock shall be subject to the same restrictions as then in effect for the Shares of
restricted stock, provided that any dividends on Shares of restricted stock that vest based upon
the satisfaction of any performance conditions shall be accumulated and paid at the time the
underlying performance conditions are satisfied. Except as otherwise provided in any Grant
Agreement, with respect to the restricted stock units, during such period of restriction the
Participant shall not have any rights as a shareholder of the Company; provided that, unless
otherwise provided in a Participant’s Grant Agreement, the Participant shall have the right to
receive accumulated dividends or distributions with respect to the corresponding number of shares
of Common Stock underlying each restricted stock unit at the end of the Vesting Period, unless such
restricted stock units are converted into deferred stock units, in which case such accumulated
dividends or distributions shall be paid by the Company to the Participant at such time as the
deferred stock units are converted into shares of Common Stock.

Unless otherwise provided in a Participant’s Grant Agreement, each unit or Share of restricted
stock shall be subject to the termination and forfeiture provisions as set forth in Section
6.e.

	9.	 	Performance Awards.

Performance awards may be granted to Participants at any time and from time to time as
determined by the Committee. The Committee shall determine the size and composition of performance
awards granted to a Participant and the appropriate period over which performance is to be measured
(a “performance cycle”). Performance awards may include (i) specific dollar-value target
awards (ii) performance units, the value of each such unit being determined by the Committee at the
time of issuance, and/or (iii) performance Shares, the value of each such Share being equal to the
Fair Market Value of a share of Common Stock. In any one calendar year, the Committee shall not
grant to any one Participant performance awards (i) payable in Common Stock for an amount in excess
of 1,000,000 shares of Common Stock, or (ii) for performance awards payable in Other Securities or
a combination of Common Stock and Other Securities, with a maximum amount payable thereunder of
more than the Fair Market Value of 1,000,000 shares of Common Stock determined either on the date
of grant of the award or the date the award is paid, whichever is greater.

The value of each performance award may be fixed or it may be permitted to fluctuate based on
a performance factor (e.g., return on equity) selected by the Committee; provided that, payment of
any performance award that is intended to qualify as “qualified performance-based compensation”
within the meaning of Treasury Regulation §1.162-27(e) shall be based solely on the satisfaction of
pre-established, objective goals determined with reference to one or more of the following
performance factors: return on equity; earnings per share; return on gross or net assets; return on
gross or net revenue; pre- or after-tax net income; earnings before interest, taxes, depreciation
and amortization; operating income; revenue growth; consolidated pre-tax earnings; net or gross
revenues; net earnings; earnings before interest and taxes; cash flow; earnings per share; fleet
in-market availability; safety criteria; environmental criteria; revenue growth; cash flow from
operations; diluted or basic; return on sales; earnings per share from continuing operations,
diluted or basic; earnings from continuing operations; net asset turnover; capital expenditures;
income before income taxes; gross or operating margin; return on total assets; return on invested
capital; return on investment; return on revenue; market share; economic value added; cost of
capital; expense reduction levels; stock price; productivity; customer satisfaction; employee
satisfaction; and total shareholder return for the applicable Performance Period, all as computed
in accordance with Generally Accepted Accounting Principles (if relevant) as in effect from time to
time and as applied by the Company in the preparation of its financial statements and subject to
such other special rules and conditions as the Compensation Committee may establish at any time
ending on or before the 90th day of the applicable Performance Period. These performance factors
may be absolute or relative (to prior performance of the Company or to the performance of one or
more other entities or external indices) and may be expressed in terms of a progression within a
specified range. The foregoing criteria shall have any reasonable definitions that the Committee
may specify, which may include or exclude any or all of the following items, as the Committee may
specify: extraordinary, unusual or non-recurring items; effects of accounting changes; effects of
currency fluctuations; effects of financing activities (e.g., effect on earnings per share of
issuing convertible debt securities); expenses for restructuring, productivity initiatives or new
business initiatives; non-operating items; acquisition expenses; and effects of divestitures.

The Committee shall establish performance goals and objectives for each performance cycle on
the basis of such criteria and objectives as the Committee may select from time to time, including,
without limitation, the performance of the Participant, the Company, one or more of its
Subsidiaries or divisions or any combination of the foregoing. During any performance cycle, the
Committee shall have the authority to adjust the performance goals and objectives for such cycle
for such reasons as it deems equitable.

The Committee shall determine the portion of each performance award that is earned by a
Participant on the basis of the Company’s performance over the performance cycle in relation to the
performance goals for such cycle. The earned portion of a performance award may be paid out in
Shares, Other Company Securities or any combination thereof, as the Committee may determine.

A Participant must be a director, officer or employee of, or otherwise perform services for,
the Company or its Subsidiaries at the end of the performance cycle in order to be entitled to
payment of a performance award issued in respect of such cycle; provided, however, unless otherwise
provided in a Participant’s Grant Agreement, each performance award shall be subject to the
termination and forfeiture provisions as set forth in Section 6.e.

Unless otherwise provided in a Participant’s Grant Agreement, if there is a Change in Control
of the Company, the Committee shall determine the level at which a Participant’s performance awards
shall become vested upon such Change in Control.

	10.	 	Deferred Stock Units.

Deferred stock units (A) may be granted to Participants at any time and from time to time as
determined by the Committee, and (B) shall be issued to Participants who elected prior to the date
the restricted stock units were granted to defer delivery of shares of Common Stock that would
otherwise be due by virtue of the lapse or waiver of the vesting requirements of their restricted
stock units. All elections with respect to deferred stock units shall be made in accordance with
the election and distribution timing rules in Code Section 409A.

Except as otherwise provided in any Grant Agreement, deferred stock units shall be granted
without payment of cash or other consideration to the Company but in consideration of services
performed for or for the benefit of the Company or any Subsidiary by such Participant. Payment of
the value of deferred stock units shall be made by the Company in shares of Common Stock; provided
that, the Participant shall receive a number of shares of Common Stock equal to the number of
matured or earned deferred stock units. Upon payment in respect of a deferred stock unit, such
unit shall be terminated and thereafter forfeited. Payments in respect of deferred stock units
shall be made only at the end of the Deferral Period applicable to such units, the duration of
which Deferral Period shall be determined by the Committee at the time of grant of such deferred
stock units and set forth in the applicable Grant Agreement (or by the Participant in the case of
an election to defer the receipt of Common Stock beyond the Vesting Period).

Except as otherwise provided in any Grant Agreement, during such Deferral Period the
Participant shall not have any rights as a shareholder of the Company; provided that, unless
otherwise provided in a Participant’s Grant Agreement, the Participant shall have the right to
receive accumulated dividends or distributions with respect to the corresponding number of shares
of Common Stock underlying each deferred stock unit at the end of the Deferral Period when such
deferred stock units are converted into shares of Common Stock.

Unless otherwise provided in the Participant’s Grant Agreement or related election form, if a
Participant dies while serving as a director, officer or employee of the Company or its Subsidiary
prior to the end of the Deferral Period, the Participant shall receive payment in respect to such
Participant’s deferred stock units which would have matured or been earned at the end of such
Deferral Period as if the applicable Deferral Period had ended as of the date of such Participant’s
death.

Unless otherwise provided in a Participant’s Grant Agreement or related election form, if a
Participant ceases to be a director, officer or employee of, or to otherwise perform services for,
the Company or its Subsidiaries upon his or her Disability or Retirement prior to the end of the
Deferral Period, the Participant shall receive payment in respect of such Participant’s deferred
stock units at the end of such Deferral Period.

Unless otherwise provided in the Participant’s Grant Agreement or related election form, at
such time as a Participant ceases to be, or in the event a Participant does not become, a director,
officer or employee of, or otherwise performing services for, the Company or its subsidiaries for
any reason other than Disability, Retirement or death, such Participant shall immediately forfeit
any unvested deferred stock units which would have matured or been earned at the end of such
Deferral Period.

	11.	 	Grant of Dividend Equivalent Rights.

The Committee may include in a Participant’s Grant Agreement a dividend equivalent right
entitling the grantee to receive amounts equal to all or any portion of the dividends that would be
paid on the shares of Common Stock covered by such Award if such Shares had been delivered pursuant
to such Award. In the event such a provision is included in a Grant Agreement, the Committee shall
determine whether such payments shall be made in cash, in shares of Common Stock or in another
form, whether they shall be conditioned upon the exercise of the Award to which they relate, the
time or times at which they shall be made, and such other terms and conditions as the Committee
shall deem appropriate. Any dividend equivalent rights that may be granted on account of Awards
that vest based upon the satisfaction of any performance conditions may only be paid if the
underlying performance conditions of the Award are satisfied.

	12.	 	Withholding Taxes.

(a) Participant Election. Unless otherwise determined by the Committee, a Participant
may elect to deliver shares of Common Stock (or have the Company withhold Shares acquired upon
exercise of an option or SAR or deliverable upon grant of restricted stock or vesting of restricted
stock units or deferred stock units or the receipt of Common Stock, as the case may be) to satisfy,
in whole or in part, the amount the Company is required to withhold for taxes in connection with
the exercise of an option or SAR or the delivery of restricted stock upon grant or vesting or the
receipt of Common Stock, as the case may be. Such election must be made on or before the date the
amount of tax to be withheld is determined. Once made, the election shall be irrevocable. The
fair market value of the shares to be withheld or delivered will be the Fair Market Value as of the
date the amount of tax to be withheld is determined. In the event a Participant elects to deliver
or have the Company withhold shares of Common Stock pursuant to this Section 12.a., such
delivery or withholding must be made subject to the conditions and pursuant to the procedures set
forth in Section 6.b. with respect to the delivery or withholding of Common Stock in
payment of the exercise price of options.

(b) Company Requirement. The Company may require, as a condition to any grant or
exercise under the Plan or to the delivery of certificates for Shares issued hereunder, that the
grantee make provision for the payment to the Company, either pursuant to Section 12.a. or
this Section 12.b., of federal, state or local taxes of any kind required by law to be
withheld with respect to any grant, delivery or vesting of Shares. The Company, to the extent
permitted or required by law, shall have the right to deduct from any payment of any kind
(including salary or bonus) otherwise due to a grantee, an amount equal to any federal, state or
local taxes of any kind required by law to be withheld with respect to any grant or delivery of
Shares under the Plan. The Company shall in no event be liable for any taxes whatsoever
(including, without limitation, taxes under Code Section 409A) associated with the grant, vesting,
exercise, or settlement of any Award granted pursuant to this Plan, other than the Company’s share
of any payroll taxes.

	13.	 	Grant Agreement; Vesting.

Each employee to whom an Award is made under the Plan shall enter into a Grant Agreement with
the Company that shall contain such provisions, including without limitation vesting requirements,
consistent with the provisions of the Plan, as may be approved by the Committee. Unless the
Committee determines otherwise and except as otherwise provided in Sections 6, 7, 8, 9, and
10 in connection with a Change of Control or certain occurrences of termination, no Award under
this Plan may be exercised, and no restrictions relating thereto may lapse, within six months of
the date such Award is made.

	14.	 	Transferability.

No Award granted under the Plan shall be transferable by a Participant other than (a) by will
or the laws of descent and distribution, (b) to a Participant’s Family Member by gift or a
qualified domestic relations order as defined by the Code or (c) to a charitable organization, but
in each case only with Committee approval or as provided in a Grant Agreement. Unless otherwise
provided in any Grant Agreement, an option, SAR or performance award may be exercised only by the
optionee or grantee thereof; by his or her Family Member if such person has acquired the option,
SAR or performance award by gift or qualified domestic relations order; by the executor or
administrator of the estate of any of the foregoing or any person to whom the Option is transferred
by will or the laws of descent and distribution; or by the guardian or legal representative of any
of the foregoing; provided that, Incentive Stock Options may be exercised by any Family Member,
guardian or legal representative only if permitted by the Code and any regulations thereunder. All
provisions of this Plan shall in any event continue to apply to any Award granted under the Plan
and transferred as permitted by this Section 14, and any transferee of any such Award shall
be bound by all provisions of this Plan as and to the same extent as the applicable original
grantee.

	15.	 	Listing, Registration and Qualification.

If the Committee determines that the listing, registration or qualification upon any
securities exchange or under any law of Shares subject to any Award is necessary or desirable as a
condition of, or in connection with, the granting of same or the issue or purchase of Shares
thereunder, no such option or SAR may be exercised in whole or in part, no such performance award,
restricted stock unit or deferred stock unit may be paid out, and no Shares may be issued, unless
such listing, registration or qualification is effected free of any conditions not acceptable to
the Committee.

	16.	 	Transfer of Employee.

The transfer of an employee from the Company to a Subsidiary, from a Subsidiary to the
Company, or from one Subsidiary to another Subsidiary shall not be considered a termination of
employment; nor shall it be considered a termination of employment if an employee is placed on
military or sick leave or such other leave of absence which is considered by the Committee as
continuing intact the employment relationship.

	17.	 	Adjustments.

(a) In the event that any reorganization, recapitalization, stock split, reverse stock split,
stock dividend, combination of shares, merger, consolidation, distribution of assets, or any other
change in the corporate structure or shares of the Company affects Shares such that an adjustment
is appropriate in order to prevent dilution or enlargement of the rights of Participants under the
Plan, the Committee shall make such equitable adjustments in any or all of the following in order
to prevent such dilution or enlargement of rights: the number and kind of Shares or other property
available for issuance under the Plan (including, without limitation, the total number of Shares
available for issuance under the Plan pursuant to Section 4), the number and kind of Awards
or other property covered by Awards previously made under the Plan, and the exercise price of
outstanding options and SARs. Any such adjustment shall be final, conclusive and binding for all
purposes of the Plan. In the event of any merger, consolidation or other reorganization in which
the Company is not the surviving or continuing corporation or in which a Change in Control is to
occur, all of the Company’s obligations regarding any Awards that were granted hereunder and that
are outstanding on the date of such event shall, on such terms as may be approved by the Committee
prior to such event, be assumed by the surviving or continuing corporation or canceled in exchange
for property (including cash).

(b) Without limitation of the foregoing, in connection with any transaction of the type
specified by clause (iii) of the definition of a Change in Control in Section 2.c., the
Committee may (i) cancel any or all outstanding options under the Plan in consideration for payment
to the holders thereof of an amount equal to the portion of the consideration, if any, that would
have been payable to such holders pursuant to such transaction if their options had been fully
exercised immediately prior to such transaction, less the aggregate exercise price that would have
been payable therefor, or (ii) if the amount that would have been payable to the option holders
pursuant to such transaction if their options had been fully exercised immediately prior thereto
would be equal to or less than the aggregate exercise price that would have been payable therefor,
cancel any or all such options for no consideration or payment of any kind. Payment of any amount
payable pursuant to the preceding sentence may be made in cash or, in the event that the
consideration to be received in such transaction includes securities or other property, in cash
and/or securities or other property in the Committee’s discretion.

(c) Change in Control. Unless otherwise provided in a Participant’s Grant Agreement, if there
is a Change in Control of the Company, all of the Participant’s Awards shall become fully vested
upon such Change in Control (and, with respect to the Participant’s options, exercisable upon such
Change in Control and shall remain so until the expiration date of the options), whether or not the
Participant is subsequently terminated.

(d) Clawback. If the Company is required to prepare an accounting restatement due to the
material noncompliance of the Company with any financial reporting requirement under the securities
laws, then any Participant who has been paid an Award under this Plan based upon or affected by the
restated financial report shall be required, at the discretion of the Board, to reimburse the
Company for all or any portion of such Award.

	18.	 	Amendment and Termination of the Plan.

The Board or the Committee, without approval of the shareholders, may amend or terminate the
Plan at any time, except that no amendment shall become effective without prior approval of the
shareholders of the Company if (i) shareholder approval would be required by applicable law or
regulations, including if required by any listing requirement of the principal stock exchange or
national market on which the Common Stock is then listed, (ii) such amendment would remove from the
Plan a provision which, without giving effect to such amendment, is subject to shareholder
approval, or (iii) such amendment would directly or indirectly increase the Share limits set forth
in Section 4 of the Plan.

	19.	 	Amendment or Substitution of Awards under the Plan.

The terms of any outstanding Award under the Plan may be amended from time to time by the
Committee in any manner that it deems appropriate (including, but not limited to, acceleration of
the date of exercise of any Award and/or payments thereunder or of the date of lapse of
restrictions on Shares); provided that, except as otherwise provided in Section 17, no such
amendment shall adversely affect in a material manner any right of a Participant under the Award
without his or her written consent, and provided further that, the Committee shall not reduce the
exercise price of any options or SARs awarded under the Plan without approval of the shareholders
of the Company. The Committee may, in its discretion, permit holders of Awards under the Plan to
surrender outstanding Awards in order to exercise or realize rights under other awards, or in
exchange for the grant of new awards, or require holders of Awards to surrender outstanding Awards
as a condition precedent to the grant of new awards under the Plan. Notwithstanding the foregoing,
the Committee shall not take any of the following actions without shareholder approval, except as
provided in Section 17: (i) reduce the exercise price following the grant of an option or
SAR; (ii) exchange an option or SAR which has an exercise price that is greater than the Fair
Market Value of a Share for cash or Shares or (iii) cancel an option or SAR in exchange for a
replacement option or another Award with a lower exercise price. Notwithstanding anything to the
contrary in this Plan, in no event shall the Committee amend the distribution terms in any Award or
Grant Agreement that has a feature for the deferral of compensation if such amendment would result
in taxes, additional interest and/or penalties pursuant to Code Section 409A.

	20.	 	Termination Date

The date of commencement of the Plan shall be July 28, 2010.

Unless previously terminated upon the adoption of a resolution of the Board terminating the
Plan, the Plan shall terminate on the tenth anniversary of the earlier of the date that the Plan is
adopted or date the of stockholder approval. No termination of the Plan shall materially and
adversely affect any of the rights or obligations of any person, without his or her written
consent, under any Award or other incentives theretofore granted under the Plan.

	21.	 	Severability.

Whenever possible, each provision of the Plan shall be interpreted in such manner as to be
effective and valid under applicable law, but if any provision of the Plan is held to be prohibited
by or invalid under applicable law, such provision shall be ineffective only to the extent of such
prohibition or invalidity, without invalidating the remainder of the Plan.

	22.	 	Governing Law.

The Plan shall be governed by the corporate laws of the State of Delaware, without giving
effect to any choice of law provisions that might otherwise refer construction or interpretation of
the Plan to the substantive law of another jurisdiction.

* * * *

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00176-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00176-of-00352.parquet"}]]